Healthcare Business Management Association - HBMA
Leading the Business of Healthcare Login
Coronavirus Disease (COVID-19) Coronavirus Disease (COVID-19) - HBMA Healthcare Business Management Association

Coronavirus Disease (COVID-19) Update

Share
09/21/2021

Congress

  • The House Select Subcommittee on the Coronavirus Crisis will meet on Wednesday for a hearing regarding pandemic relief programs.

White House and Federal Agencies

  • The Biden Administration announced it will ease travel restrictions for vaccinated international visitors beginning in November.
  • The Biden Administration plans to purchase more Pfizer vaccines to donate around the world.

Economy, Vaccine, Testing and Treatment

  • The FDA Vaccines and Related Biological Products Advisory Committee voted unanimously (18-0) to approve a third “booster” dose of the Pfizer COVID-19 vaccine for at risk individuals only, including health care workers and people over 65. The advisory committee voted (16-2) against a recommendation for booster doses for the general population.
    • National Institute of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci and National Institutes of Health (NIH) head Dr. Francis Collins expressed support for the advisory panel’s recommendation.
    • However, Dr. Collins anticipates the FDA to extend a third dose recommendation to more individuals soon as they receive more data. 
  • Pfizer says it has completed a successful vaccine trial for children aged five to eleven. They are now filing for FDA authorization.
  • A new CDC study shows how the three FDA-authorized COVID-19 vaccines remain effective at preventing hospitalization over time.
    • The study found that Moderna’s vaccine offered the highest protection (93%) followed by Pfizer-BioNTech (88%) and the Johnson & Johnson vaccine (71%).
  • A new study shows surgical masks are more effective than cloth masks in preventing infections from the Delta variant.
  • This article describes what a “mild” breakthrough case is like.
  • Pfizer says it has completed a successful vaccine trial for children aged five to eleven. They are now filing for FDA authorization.
  • A new CDC study shows how the three FDA-authorized COVID-19 vaccines remain effective at preventing hospitalization over time.
    • The study found that Moderna’s vaccine offered the highest protection (93%) followed by Pfizer-BioNTech (88%) and the Johnson & Johnson vaccine (71%).
  • A new study shows surgical masks are more effective than cloth masks in preventing infections from the Delta variant.
  • This article describes what a “mild” breakthrough case is like.

 
Centers for Disease Control and Prevention (CDC) Updates